Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 2012. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, rather than a comprehensive financial report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document is limited to reporting a specific share transaction.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The only reported activity is the exercise of share options by a connected person.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. It strictly details a compliance notification under Disclosure Rule 3.1.4R(1)(a) and (c).
Important Facts for Investors
- Transaction Type: Exercise of share options under the GlaxoSmithKline plc Sharesave Plan.
- Individuals Involved: Mr. P C Thomson (Director/PDMR) and Mrs. K Thomson (Connected Person).
- Transaction Details: 746 Ordinary shares purchased on December 3, 2012, at a price of £9.72 per share.
- Grant Date: The options were originally granted on December 1, 2009.
- Notification Date: The company was advised of the transaction on December 7, 2012.